A citation-based method for searching scientific literature

Hideyuki Arita, Kai Yamasaki, Yuko Matsushita, Taishi Nakamura, Asanao Shimokawa, Hirokazu Takami, Shota Tanaka, Akitake Mukasa, Mitsuaki Shirahata, Saki Shimizu, Kaori Suzuki, Kuniaki Saito, Keiichi Kobayashi, Fumi Higuchi, Takeo Uzuka, Ryohei Otani, Kaoru Tamura, Kazutaka Sumita, Makoto Ohno, Yasuji Miyakita, Naoki Kagawa, Naoya Hashimoto, Ryusuke Hatae, Koji Yoshimoto, Naoki Shinojima, Hideo Nakamura, Yonehiro Kanemura, Yoshiko Okita, Manabu Kinoshita, Kenichi Ishibashi, Tomoko Shofuda, Yoshinori Kodama, Kanji Mori, Yusuke Tomogane, Junya Fukai, Koji Fujita, Yuzo Terakawa, Naohiro Tsuyuguchi, Shusuke Moriuchi, Masahiro Nonaka, Hiroyoshi Suzuki, Makoto Shibuya, Taketoshi Maehara, Nobuhito Saito, Motoo Nagane, Nobutaka Kawahara, Keisuke Ueki, Toshiki Yoshimine, Etsuo Miyaoka, Ryo Nishikawa, Takashi Komori, Yoshitaka Narita, Koichi Ichimura. Acta Neuropathol Commun 2016
Times Cited: 111



Olivier L Chinot, Wolfgang Wick, Warren Mason, Roger Henriksson, Frank Saran, Ryo Nishikawa, Antoine F Carpentier, Khe Hoang-Xuan, Petr Kavan, Dana Cernea, Alba A Brandes, Magalie Hilton, Lauren Abrey, Timothy Cloughesy. N Engl J Med 2014
Times Cited: 1358




List of shared articles



Times cited

Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH-wildtype glioblastoma.
Yusuke Funakoshi, Nobuhiro Hata, Kosuke Takigawa, Hideyuki Arita, Daisuke Kuga, Ryusuke Hatae, Yuhei Sangatsuda, Yutaka Fujioka, Aki Sako, Toru Umehara,[...]. Cancer Med 2021
1

Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastoma.
Kosuke Takigawa, Nobuhiro Hata, Yuhei Michiwaki, Akio Hiwatashi, Hajime Yonezawa, Daisuke Kuga, Ryusuke Hatae, Yuhei Sangatsuda, Yutaka Fujioka, Yusuke Funakoshi,[...]. J Neurooncol 2021
0


First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide.
Nobuhiro Hata, Masahiro Mizoguchi, Daisuke Kuga, Ryusuke Hatae, Yojiro Akagi, Yuhei Sangatsuda, Takeo Amemiya, Yuhei Michiwaki, Yutaka Fujioka, Kosuke Takigawa,[...]. J Neurooncol 2020
8

Development of a gene expression-based prognostic signature for IDH wild-type glioblastoma.
Radia M Johnson, Heidi S Phillips, Carlos Bais, Cameron W Brennan, Timothy F Cloughesy, Anneleen Daemen, Ulrich Herrlinger, Robert B Jenkins, Albert Lai, Christoph Mancao,[...]. Neuro Oncol 2020
5

High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas.
Ivana Jovčevska, Alja Zottel, Neja Šamec, Jernej Mlakar, Maxim Sorokin, Daniil Nikitin, Anton A Buzdin, Radovan Komel. Cancers (Basel) 2019
6

From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence.
A Zygogianni, M Protopapa, A Kougioumtzopoulou, F Simopoulou, S Nikoloudi, V Kouloulias. Clin Transl Oncol 2018
6

Treatment of Glioblastoma in the Elderly.
Rebecca A Harrison, John F de Groot. Drugs Aging 2018
6

Glioma Subclassifications and Their Clinical Significance.
Ricky Chen, Matthew Smith-Cohn, Adam L Cohen, Howard Colman. Neurotherapeutics 2017
143